搜尋結果
Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News ...
Reuters· 2 小時前Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be ...
Who is Cher’s youngest son, Elijah Blue Allman, and where is he now?
South China Morning Post· 4 小時前Pop legend Cher has dropped her bid for conservatorship over her son, Elijah Blue Allman, as ...
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Reuters· 6 小時前Elon Musk's brain-chip startup Neuralink said on Tuesday its implant aimed at restoring vision received the U.S. Food and ...
Healthy Returns: How competitive can Roche be in the weight loss drug market?
CNBC· 6 小時前Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk ...
US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month
Reuters· 7 小時前Novo Nordisk CEO Lars Jorgensen is set to testify before the Senate Committee on Health, ...
French man admits decade-long abuse of wife
China Daily· 7 小時前Dominique Pelicot, the 71-year-old French man accused of drugging his then-wife and inviting dozens of men to rape her over ...
Ozempic ‘Very Likely’ to Face Drug Price Negotiations, Novo Says
Bloomberg· 8 小時前Have a confidential tip for our reporters? Ozempic, the blockbuster diabetes shot made by Novo ...
Arzeda is using AI to design proteins for natural sweeteners and more
TechCrunch· 9 小時前AI is increasingly being applied to protein design, the process of creating new proteins with ...
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
CNBC· 9 小時前BLCO's estimated 2025 earnings before interest, taxes, depreciation and amortization is ...
UBS says get defensive as global growth disappoints. Gives stocks to buy
CNBC· 11 小時前As global growth continues to slow, investors should get overweight on defensive names, ...
